Connection

Jean-Michel Dogné to Clinical Trials as Topic

This is a "connection" page, showing publications Jean-Michel Dogné has written about Clinical Trials as Topic.
Connection Strength

0.011
  1. Idarucizumab for the treatment of hemorrhage and dabigatran reversal in patients requiring urgent surgery or procedures. Expert Opin Biol Ther. 2017 10; 17(10):1275-1296.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.